In addition to breast cancer, the potential of Capivasertib in the treatment of other types of cancer (such as prostate cancer, lung cancer and renal cell cancer) is also gradually emerging.
With the development of precision medicine, Capivasertib may be combined with genetic testing technology to achieve more personalized cancer treatment.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: